Mytos

Private

LondonHealthcare & Life Scienceshttps://www.mytos.bio/

Last Round

Series A

Nov 30, 2023

Est. Valuation

$1.71M

Total Funding Raised

$21.24M

Company Overview

Mytos is a biotechnology company that has developed a fully automated platform for human cell manufacturing, designed to serve pharmaceutical and biotechnology businesses.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

automated cell culturecell therapy manufacturingCDMOcontract development and manufacturing organizationbiotech automationlab automationregenerative medicinebioprocessingrobotic cell culturecell line developmentdrug discoverybiotech hardwareclinical grade manufacturingbio-manufacturinglab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mytos Comps

Public and private peers based on sector, stage, and business model.

Mytos comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mytos Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 30, 2023
Accelerator	Aug 20, 2018
Seed	Aug 1, 2018
Accelerator	Jun 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Ali Afshar

CEO Co-Founder

Founding Team

Mytos Investors

Notable investors and investment history

Mytos investors
Investor	Rounds
Cathexis	Seed
Deep Science Ventures	Seed
Acequia Capital	Seed
Hoxton Ventures	Seed
AiSprouts VC	Seed
IQ Capital	Series A
Buckley Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 3, 2025
Partnered with Novadip to power next-generation cell therapy trials.
Sep 3, 2025
Partnered with Rinri Therapeutics for cell therapy trials.

View all signals

Mytos Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Mytos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mytos's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon

Employee Range48

Year Founded2016

Last FundingNov 30, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.